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MIP-1αWe studied cytokine responses to inﬂuenza virus PR8 (H1N1) and Oklahoma/309/06 (OK/06, H3N2) in a
novel human lung tissue model. Exposure of the model to inﬂuenza virus rapidly activated the mitogen-
activated protein kinase signaling (MAPK) pathways ERK, p38 and JNK. In addition, RNase protection assay
demonstrated the induction of several cytokine and chemokine mRNAs by virus. This ﬁnding was reﬂected at
the translational level as IL-6, MCP-1, MIP-1α/β, IL-8 and IP-10 proteins were induced as determined by
ELISA. Immunohistochemistry for IP-10 and MIP-1α revealed that alveolar epithelial cells and macrophages
were the source of these two cytokines. Taken together, both PR8 and OK/06 cause similar induction of
cytokines in human lung, although OK/06 is less effective at inducing the chemokines MCP-1 and IL-8. This
human organ culture model should thus provide a relevant platform to study the biological responses of
human lung to inﬂuenza virus infection.
Published by Elsevier Inc.Introduction
In the United States, inﬂuenza annually infects 5–20% of the
population, hospitalizes 200,000, and kills 36,000. Thus, it is a leading
cause of death (Izurieta et al., 2000; Thompson et al., 2004). The
devastating Spanish inﬂuenza A virus infected about a third of the
world's population and killed 40 million people during the pandemic
of 1918.
Following replication in the superﬁcial cells of the respiratory
tract, inﬂuenza virus causes a spectrum of acute clinical syndromes
that can progress to a fatal outcome. The clinical syndromes include
asymptomatic infection and primary viral or secondary bacterial
pneumonia. Therefore, although the virus infects the entire respira-
tory tract, morbidity and mortality is associated with lower
respiratory tract involvement (Hers, 1966; Hers et al., 1958; Hers
and Mulder, 1961).
Human inﬂuenza virus belongs to the orthomyxoviridae family,
which consists of four genera: inﬂuenza A, B, and C virus, and
Thogovirus. Only inﬂuenza virus A and B are pathogenic amonghuman
beings. Inﬂuenza A viruses are further subdivided into subtypes basedInc.on the antigenicity of two transmembrane glycoproteins, hemagglu-
tinin (HA) and neuraminidase (NA). There are 16 HA and 9 NA
subtypes in inﬂuenza virus A. Viruses with HA types H1–H3 and NA
types N1 and N2 are found in humans.
Epithelial cells are the primary site of viral replication for inﬂuenza,
although monocytes/macrophages and other leukocytes can also be
infected (Ronni et al., 1997). Inﬂuenza virus speciﬁc antigen has been
found in type 1 and type 2 alveolar epithelial cells, aswell as in alveolar
macrophages. Viruses initiate infection by binding of the viral HA to
sialic acid on the cell surface and enter the cells by receptor-mediated
endocytosis. Once inside the cells, inﬂuenza virus shuts off host cell
protein synthesis and replicates in a fast and efﬁcientway. This process
results in host cell apoptosis or death by cytolysis. However, the host
cells respond in several ways to limit viral spreading. The most
signiﬁcant response is production of cytokines and chemokines by
epithelial cells and leukocytes via activation ofmultiple transcriptional
and posttranslational systems (Julkunen et al., 2000). Cytokines are
extracellular signal proteins that stimulate adjacent anddistant cells to
activate host antiviral defense. Chemokines are low molecular weight
chemoattractant cytokines which bind to their speciﬁc receptors in
leukocytes, recruit inﬂammatory cells to the site of infection, and
activate innate immune responses (Baggiolini, 1998). Cytokines are
released from lung epithelial cell lines during inﬂuenza virus infection.
These include type 1 IFN (Ronni et al., 1997), IL-6 and the chemokines
Fig. 1. Exposure of human lung tissue to inﬂuenza virus results in infection and
replication in alveolar epithelial cells. (A) Infection assessed by the use of ﬂuorescently
labeled inﬂuenza virus. Labeled virus was separated from the unconjugated dye by
dialysis against multiple changes of PBS at 4 °C. Tissue slices exposed to virus diluent
179W. Wu et al. / Virology 396 (2010) 178–188MCP-1, RANTES, and IL-8 (Adachi et al., 1997; Kawaguchi et al., 2000;
Matsukura et al., 1996). In addition, IL-6, TNF-α, MIP-1α, MIP-1β and
IL-8 have also been detected in the nasopharyngeal secretions of
inﬂuenza A virus infected patients (Fritz et al., 1999; Kaiser et al.,
2001). Monocytes also secrete chemokines during inﬂuenza exposure,
includingMIP-1α, MIP-1β, MIP-3α, MCP-1, MCP-3, RANTES, IP-10 and
cytokines TNF-α, IL-1β, IL-6, IL-18 and IFN α/β (Bussfeld et al., 1998;
Garn et al., 2002; Pirhonen et al., 2001; Sprenger et al., 1996).
We have developed a human lung organ culture model in order to
study the local lung response to human pathogens (Booth et al., 2004;
Chakrabarty et al., 2007). Precision-cut lung slices have frequently
been used in toxicology studies and have advantages over the use of
isolated, cultured epithelial cells for infectious disease studies. The
structural integrity of lung tissue is maintained (Placke and Fisher,
1987) and this allows for cell–cell interaction in a more complex and
native three-dimensional system. Detailed mechanistic studies of
intracellular processes such as signal pathway activation can be
examined in human tissue without risk to the host.
The primary strategy against viral epidemics and pandemics has
been development of vaccines. Alternate strategies are likely to be
necessary for strains for which development of a vaccine is
problematic. One step in developing these strategies is to understand
local, i.e., pulmonary, responses to these strains. As nearly all prior
cytokine induction studies have been carried out with H1N1 (mostly
A/ PR8/34) strains, very little is known about the pulmonary
responses to inﬂuenza virus subtype H3N2. Even in the cases of
H1N1 virus, few studies have been done in humans, and none have
examined the pathophysiology of human lung infection. Therefore,
this paper will investigate the innate immune response of the human
lung to both a recently isolated, unadapted H3N2 strain, A/
Oklahoma/309/06 (OK/06) and the commonly used, mouse adapted,
H1N1 strain (PR8).
In our current study, we demonstrated that human lung responds
to inﬂuenza virus by induction of the MAPK pathways ERK, SAPK/
JNK, and p38. This is followed by an increase in the production of
several cytokines and chemokines at both the transcriptional and
translational levels. The importance of signal pathway activation in
cytokine induction was determined by measurement of the induction
by virus in the presence or absence of chemical inhibitors of the
pathways. The sources of cytokines MIP-1α and IP-10 are both
alveolar macrophages and epithelia, with a possible, smaller
contribution by interstitial cells.were used as a negative control for virus detection. The left panel shows no detection of
red ﬂuorescence in tissue exposed to virus diluent. The right panel shows exposure of
the tissue to Cy3 virus for 18 h resulted in detection of virus in multiple cells. (B)
Replication of inﬂuenza virus PR8 (H1N1) and OK/06 (H3N2) in the human lung organ
culture model. Lung slices exposed to virus were cultured for various times and total
mRNA in the lung slices was extracted. RT-PCR was performed using Oligo dT as the
primer for the ﬁrst strand synthesis. Primers speciﬁc for NS1 were used to examine NS1
mRNA expression.Results
Human lung slices in culture support inﬂuenza virus replication and
infection
Lung slices were processed by frozen section for detection of Cy3
labeled inﬂuenza virus. There was no detectable red ﬂuorescence in
tissue exposed to virus diluent (Fig. 1A, left panel). Exposure of the
tissue to Cy3-OK/06 for 18 h resulted in detection of ﬂuorescently
labeled virus associated with multiple cells, which appear morpho-
logically to be alveolar epithelial cells (Fig. 1A, right panel). Thus, the
human lung slices support infection during exposure to inﬂuenza
virus.
Inﬂuenza virus infection was measured in tissue slices by
semiquantitative RT-PCR. The results demonstrated signiﬁcant pro-
duction of viral nonstructural protein 1 (NS1) mRNA with a peak by
8 h, which remained elevated, but gradually declined as infection
continued (Fig. 1B). This demonstrated that the human lung slice
model was permissive for human inﬂuenza virus replication. This data
also demonstrated the intraslice reproducibility of total cell density, as
shown by the similar levels of GAPDH, determined by semiquantita-
tive RT-PCR from different individual slices.RNA expression of cytokines and chemokines by human lung slices
exposed to inﬂuenza virus
We ﬁrst examined the innate immune cytokine and chemokine
response of human lung tissue to inﬂuenza virus using RNase
protection assay (RPA). Lung slices were exposed to 6×106 PFU/ml
or virus diluent (negative control) for 4, 8, 12, 16, 20 and 24 h. RPA
for cytokines demonstrated a 2- to 10-fold mRNA induction of IL-6,
IL-8, MIP-1α, IP-10, TNF-α, MCP-1, and IFN γ. Inﬂuenza virus
caused a signiﬁcant time-dependent induction of cytokines IP-10
and IFN γ in lung tissue. The peak induction by PR8 occurred at 12
h postinfection for most of the cytokines while OK/06 peak
induction was later, at 16 h postinfection (Fig. 2). The chemokine
IP-10, whose receptors are found on activated T lymphocytes and
natural killer cells (Dufour et al., 2002; Loetscher et al., 1996), was
Fig. 2. Cytokine and chemokine mRNA response of human lung to inﬂuenza virus
infection. Human lung tissue slices (3 slices per data point) were exposed to 6×106
PFU/ml of inﬂuenza virus PR8 (A) and OK/06 (B). Equal volumes of virus diluent were
used as a negative control. mRNA expression levels were determined using a custom
cytokine template (see Materials and methods). Fold increase was determined by
normalization for levels of housekeeping genes present in each sample.
Fig. 3. Inﬂuenza virus stimulates chemokine and cytokine release in human lung. For
each data point, multiple lung slices were exposed to 6×106 PFU/ml of inﬂuenza virus
PR8 and OK/06 and allowed to incubate at 37 °C, 5% CO2 for the indicated periods.
Virus diluent was used as a negative control, and PMA (100 ng/ml) was used as a
positive control. Chemokine and cytokine protein levels were determined by ELISA on
lung slice supernatants. Data are expressed as the means±SEM from three separate
lung slice donor experiments. Statistical signiﬁcance was determined by ANOVA.
Means were compared to data from the negative control group. ⁎Pb0.05; ⁎⁎Pb0.01;
NS represents no signiﬁcant difference.
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As to the patterns of cytokines induced, there was no discernable
difference in induction for the two viral strains. Thus, RPA results
suggest a broad cytokine immune response and also a monocyte
and neutrophil chemokine response to inﬂuenza virus exposure by
human lung.
Induction of cytokines in human lung tissue infected with inﬂuenza virus
RPA data indicated inﬂuenza induction of mRNA levels of several
cytokines and chemokines. To conﬁrm that this increase in mRNAwas
reﬂected at the level of translation, we tested for the corresponding
cytokine protein in supernatants of lung slices exposed to inﬂuenza
virus for 6, 20, 30 and 40 h using ELISA. Human lung slices were mock
treated with virus diluent, treated with 6×106 PFU/ml of inﬂuenza
virus or treatedwith PMA (100 ng/ml) as a positive control. Consistent
with the RPA results, we saw an increase in the cytokines IL-6 and the
chemokines IL-8, MCP-1, IP-10 and MIP-1α/β with virus exposure
(Fig. 3). Speciﬁcally, therewas a peak fold increase over background in
PR8-induced cytokine and chemokine levels of IL-6, IP-10, IL-8,MCP-1,
and MIP-1α/β of 16, 75, 2, 12 and 50, respectively. MIP-1α/β
maximum levels were seen at 20 h, IL-8 at 30 h while the maximum
increase in IL-6, IP-10 and MCP-1 were seen at 40 h. At all the times
tested, MCP-1 was stimulated to a greater extent than that seen with
the positive control, 100 ng/ml of PMA (Fig. 3C). The most stimulated
cytokine was IP-10, 75-fold over mock, which is consistent with the
RPA result showing IP-10 is the most highly induced cytokine at the
Fig. 4. Kinetics of ERK1/2, SAPK/JNK and p38 phosphorylation by inﬂuenza virus in
human lung slices. Human lung tissue slices were exposed to 6×106 PFU/ml of
inﬂuenza virus PR8 and OK/06 for the times indicated. Lung lysates were prepared, and
levels of total and phosphorylated ERK1/2 (A, B, and C), p38 (D, E, and F), and SAPK/JNK
(G, H, and I) were assessed by Western blot analysis. PMA (100 ng/ml) was used as
positive controls, and virus diluent was used as a negative control. Western blots were
probed with antibody speciﬁc for phosphorylated ERK1/2 (A), p38 (D), or SAPK/JNK
(G) are shown. Identically prepared blots were also probed with pan-anti-kinase
antibody against ERK1/2 (B), p38 (E), or SAPK/JNK (H). Activation as determined by
the ratio of phosphorylated kinase/total kinase for ERK1/2 (C), p38 (F), and SAPK/JNK
(I) is graphed as shown.
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suggests that the human lung innate response involving IP-10 is
speciﬁc to virus (Fig. 3E). Although we saw a signiﬁcant induction of
IFN-γ mRNA in the RPA, IFN-γ protein levels were low (less than
100 pg/ml) in lung slice supernatants, and undetectable in lung tissue
extracts (data not shown). However, as IP-10 (10 kDa interferon-
gamma-induced protein) is secreted by several cell types in response
to IFN-γ (Luster et al., 1985), induction of IP-10 suggests that IFN-γ
induction may have occurred in our system despite the ELISA results.
For the most part, PR8 and OK/06 caused similar induction of most of
the cytokines tested except MCP-1 and IL-8. OK/06 more weakly
induces MCP-1 than PR8, at two of the four times tested. For IL-
8 induction, OK/06 also appears to induce IL-8 less readily than PR8,
but this only reached statistical signiﬁcance at 30 h after infection.
These results show that the induction of cytokine and chemokine
genes, as determined by RPA, is consistently reﬂected at the protein
level. As such, both inﬂuenza virus strains induced a broad innate
immune chemokine and cytokine response in human lung.
Induction of MAPK signaling pathways in human lung slices exposed to
inﬂuenza virus
To determine the role of signal pathway activation in cytokine and
chemokine induction by inﬂuenza virus in human lung, we next
studied the kinetics of virus-induced activation of the MAPK signaling
cascades. We assessed ERK, SAPK/JNK, and p38 activation as exhibited
by phosphorylation in human lung infected with virus (6×106 PFU/
ml). Stimulation with PMA (100 ng/ml) for 1 h served as a positive
control for phosphorylation, and mock-infected, unstimulated lysates
were prepared at 1 and 8 h as a negative control. At various times after
infection, lung lysates were prepared, and total and phosphorylated
ERK, SAPK/JNK, and p38 levels were assessed by Western blot
analysis. Membranes were also probed for total ERK, p38 and JNK
MAPK as a control for protein loading (Rodriguez-Viciana et al., 2006;
Williams et al., 2001). Phosphorylation was assessed by determining
the ratio of phosphorylated (Figs. 4A, D and G) to total kinase (Figs. 4B,
E and H), and the resultant activities were graphed (Figs. 4C, F and I).
The ratio corrects for variations in the amount of sample protein
loaded onto SDS–PAGE gels. These results revealed that ERK, SAPK/
JNK, and p38 were all activated by either, or both, of the inﬂuenza
virus strains in the human lung organ culture model.
For PR8, p38 and JNK were activated and were greatest at the last
time point measured (8 h). Activation of p38 and SAPK/JNK at that
time was 2.7- and 1.9-fold, respectively, over mock-infected controls.
PR8-induced ERK phosphorylation exhibited a constant, moderate
increase over the negative control at all times tested, ranging from
1.1- to 1.5-fold. For OK/06, ERK phosphorylation also exhibited a
constant, moderate increase over the negative control at most times
tested, ranging from 1.2- to 1.7-fold. With this strain, in contrast to
PR8, activation of p38 occurred soon after infection, and declined
thereafter. Also, in contrast to PR8, no induction of JNK was evident
during the experiment. These results indicate that exposure to
inﬂuenza virus elicits a modest increase in ERK, SAPK/JNK, and p38
activation which precedes cytokine mRNA induction and depends on
the inﬂuenza virus strain used.
Requirement for activation of multiple signaling pathways in cytokine
induction by inﬂuenza virus
The ﬁndings described above demonstrated that the MAPK
signaling pathways are activated when human lung slices are exposed
to inﬂuenza virus. We next sought to determine whether the
activation of these signaling pathways is essential for the induction
of cytokines. Lung slices were preincubated for 4 h in medium with
50 μMof the ERK pathway inhibitor U0126, 0.5 μMof the p38 pathway
inhibitor SB203580, or 0.5 μM of the SAPK/JNK pathway inhibitorSP600125. For human lung, these doses were sufﬁcient to inhibit
induction of their corresponding signaling pathways by PMA/LPS. A
combination of the three inhibitors was also used. The inhibitors
remained in the medium throughout the duration of the experiment,
and slices that were not treated with inhibitors were exposed to an
inhibitor solvent (DMSO) as an additional control. The lung slices
were incubated for 20 h either with virus (6×106 PFU/ml) or with
PMA (100 ng/ml) prior to collection of the supernatants for cytokine
and chemokine determination.
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pathway activation for the induction of speciﬁc cytokines by inﬂuenza
virus (Fig. 5). With the exception of virus induction of IL-8 and MIP-Fig. 5. Inhibition of inﬂuenza virus induction of cytokines and chemokines by signal
pathway inhibitors. Human lung tissue slices were preincubated with 0.5 μM of
SB203580, 0.5 μM of SP600125 and 50 μM of U0126, or all three together (mixture) or
inhibitor solvent (Mock), and the concentrations of these reagents was maintained
throughout. Slices were then exposed to virus diluent, 6×106 PFU/ml of inﬂuenza virus
PR8 and OK/06, or PMA (100 ng/ml) for 20 h prior to the measurement of cytokines
and chemokines by ELISA. The data are expressed as the means±SEM of four
experiments, and three tissue slices were used per experiment. Statistical signiﬁcance
was determined by ANOVA. Means were compared to data from the virus-infected
control group without inhibitors. ⁎Pb0.05; ⁎⁎Pb0.01.1α/β, addition of any of the three inhibitors diminished cytokine and
chemokine induction by inﬂuenza virus. In the case of MIP-1α/β,
inhibition of the p38 pathway individually did not alter induction of
this chemokine by virus. For all cytokines and chemokines tested,
inhibition of all three pathways appeared to enhance blockade of
virus-mediated cytokine and chemokine induction.
OK/06 was more sensitive to the p38 inhibitor, SB203580, for IL-6
induction than PR8, but not for induction of MIP-1α/β, MCP-1, IP-10
and IL-8. PR8-induced MCP-1 and IP-10 were p38 dependent while
MIP-1α/β induction was likely independent of activation of this
pathway. The different sensitivities of the two strains to inhibitors
were not likely due to inhibitor-caused viral replication defects since
NS1 gene expression of both strains was not affected in inhibitor
treated tissue (data not shown).
Cellular source of cytokine induction by inﬂuenza virus
To determine the lung cellular elements that participate in the
lung innate immune cytokine response to inﬂuenza virus, we
performed immunohistochemistry on virus-exposed lung slices.
Lung slices were exposed to virus at 6×106 PFU/ml or virus buffers
for 24 h in the presence of Brefeldin A to enhance detection of
cytokines. The slices were then processed for immunohistochemistry
for detection of inﬂuenza virus nucleoprotein (NP) and the cytokines
MIP-1α and IP-10. Macrophages were also detected by using an anti-
CD 68 polyclonal antibody (De Groot et al., 1997; Noorman et al.,
1997). Tissues exposed to virus diluent were used to demonstrate
basal cytokine and chemokine detection. An additional negative
control was performed for MIP-1α and IP-10 detection by using the
same staining protocol but with the MIP-1α or IP-10 primary
antibody omitted. There was minimal background immunoﬂuores-
cence in the absence of MIP-1α and IP-10 primary antibodies (Figs. S1
and S2). MIP-1α and IP-10 detection were signiﬁcantly enhanced by
inﬂuenza virus infection (Figs. 6 and 7, panels C). BothMIP-1α and IP-
10 were detected in both epithelial cells and CD 68+ alveolar
macrophages (Figs. 6 and 7, panels F). There were also scattered
interstitial cells that also stained positive for MIP-1α and IP-10. The
results indicate that both lung epithelia and alveolar macrophages
contribute to the innate immune response through induction of
cytokines. Additional interstitial cells may also contribute to this
response. There is no obvious cell speciﬁcity difference for cytokine
expression between the two inﬂuenza strains.
Discussion
Host innate immunity is the ﬁrst line of protection against
infection by virus and is essential in local control of invading
microbes. The innate immune system is composed of macrophages,
neutrophils, natural killer cells and dendritic cells which play crucial
roles in the initiation and subsequent direction the of adaptive
immune response, as well as in promoting localized inﬂammation and
producing cytokines that recruit additional leukocytes to the site of
infection. However, unrestrained or excessive stimulation of the
innate immune response can be harmful. The recent study from
Kobasa et al. using reconstructed 1918 inﬂuenza virus in macaques
revealed that the unprecedented lethality of the 1918 pandemic virus
is linked to an aberrant innate immune response (Kobasa et al., 2007).
Similar analysis of mice infected with the reconstructed 1918
inﬂuenza virus also demonstrated an increased and accelerated
activation of host immune response genes associated with severe
pulmonary pathology (Kash et al., 2006). With increased mobility of
potentially infected subjects due to modern travel, concern has been
raised about the introduction of highly pathogenic avian inﬂuenza
viruses into humans and the possibility, if adaptation of the virus
enables person-to-person spread, of a resultant worldwide pandemic.
Therefore, a comprehensive understanding of the human innate
Fig. 6. Cellular source of MIP-1α induction by inﬂuenza virus in human lung. Lung slices were exposed to 6×106 PFU/ml of inﬂuenza virus PR8 and OK/06 or virus diluent for 24 h in
the presence of BFA to enhance detection of cytokines. The slices were then processed for immunohistochemistry for detection of the chemokine MIP-1α using goat polyclonal
antibodies, viral nucleoprotein (NP) using rabbit polyclonal antibody and macrophages using an anti-CD 68 polyclonal antibody. Panels E are brightﬁeld images that demonstrate
that lung architecture is preserved during the experiment. The rest of the panels are ﬂuorescent images that demonstrate nuclei (panels A, blue), NP (panels B, red), MIP-1α (panels
C, green) and macrophages (panels D, cyan). Panels F are overlays of the ﬂuorescent images and demonstrate that the primary cellular sources of the cytokines are alveolar
macrophages (arrows) and epithelial cells. Some interstitial cells are also positive for MIP-1α. The bar represents 100 μm.
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standing the contribution of host immune responses to virulent
inﬂuenza virus infections is an important starting point for the
identiﬁcation of prognostic indicators and the development of novel
antiviral therapies.
Our current study examines the interaction of inﬂuenza virus with
human lung tissue. Inﬂuenza virus induces a strong pro-inﬂammatory
cytokine and a monocyte and lymphocyte chemokine response in
human lung tissue, as shown by our RPA and ELISA results (Figs. 2and 3). Speciﬁcally, this response includes induction of the cytokines
IL-6 and IFN-γ, the monocyte chemokines MIP-1 α/β and MCP-1, the
neutrophil chemokine IL-8, and the lymphocyte chemokine IP-10.
Immunohistochemistry data clearly shows that MIP-1α and IP-10 are
induced not only in macrophages, as is traditionally thought, but also
in alveolar epithelial cells. This discovery suggested epithelial cells
may play more important roles in contributing to the pathogenesis of
airway inﬂammation caused by inﬂuenza virus infection. Prior to the
data presented in this work, only IL-6, IL-8, MCP-1, Eotaxin and
Fig. 7. Cellular source of IP-10 induction by inﬂuenza virus. Lung slices were exposed to 6×106 PFU/ml of inﬂuenza virus PR8 and OK/06 or virus diluents for 24 h in the presence of
BFA to enhance detection of cytokines. The slices were then processed for immunohistochemistry for detection of the chemokine IP-10 using goat polyclonal antibodies, viral NP
using rabbit polyclonal antibody and macrophages using an anti-CD 68 polyclonal antibody. Panels E are brightﬁeld images that demonstrate that lung architecture is preserved
during the experiment. The rest of the panels are ﬂuorescent images that demonstrate nuclei (Panels A, blue), NP (Panels B, red), IP-10 (Panels C, green) andmacrophages (Panels D,
cyan). Panels F are overlays of the ﬂuorescent images and demonstrate that the primary cellular sources of the cytokines are alveolarmacrophages (arrows) and epithelial cells. Some
interstitial cells are also positive for IP-10. The bar represents 100 μm.
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human epithelial cells, or cell lines in culture (Adachi et al., 1997; Choi
and Jacoby, 1992; Kawaguchi et al., 2000; Matsukura et al., 1996).
Macrophages and dendritic cells have been the traditional focal points
for study of the initial innate immune response to inﬂuenza virus
infection and are, of course, important in the response to the
pathogen. However, the lung epithelium is the ﬁrst site of exposure
for virus and contains a large, 80 m2 surface area for viral contact.
Thus, due to the sheer number of the cells involved, and our
demonstration that these cells respond to the virus with elaborationof cytokine, and chemokines, the contribution of these cells to the
innate immune response is likely signiﬁcant.
Our human lung organ culture model, unlike artiﬁcial models
using differentiated cell lines, reproduces the normal lung architec-
ture as it maintains the three dimensional structure present in native
tissue. Also, current cell culture models lack the diversity of cell types
found in normal lung. Thus, complex interactions of the different cell
types in the native lung are not accurately modeled in cultured cell
lines, but are closely replicated and reproduced structurally in our
model. It is likely that the diverse cytokine and chemokine responses
185W. Wu et al. / Virology 396 (2010) 178–188to inﬂuenza presented herein more accurately describe the actual
lung innate immune response to the viruses.
One limitation of our study is that some of the lung tissue used was
from patients who were undergoing resection for lung cancer. Thus,
they are older, frequently suffer from COPD, and usually have previous
cigarette smoke exposure. These patient-speciﬁc factors have variable
effects on cytokine responses to stimuli. However, the overall
responses, though not the magnitude or exact timing of the cytokine
responses, are frequently comparable (Gaschler et al., 2008; Hackett
et al., 2008). We have found that in the general group of patients from
whom we have obtained tissues there are consistent cytokine
responses to stimuli not only from slice to slice, but also from donor
to donor. Thus, we believe that although the magnitude of the
responses might be different, the overall characteristics of the
responses are likely similar to those that occur in patients affected
with inﬂuenza virus. Furthermore, we included in the inhibitor
experiment both tissues from surgeries and from National Disease
Research Interchange (NDRI). The overall cytokine responses of the
lung from resection are comparable to a healthy human lung (Fig. 5 vs.
Fig. 3 at 20 h after infection).
The initial phase of inﬂuenza virus infection is characterized by
neutrophilic inﬁltration followed by a mixed monocytic/neutrophilic
inﬁltration from the peripheral blood across the endo-/epithelial
barrier into the alveolar air space (Toms et al., 1977). Later, the
airways are ﬁlled with exudates containing monocytes and lympho-
cytes (Haesebrouck et al., 1985; Van Reeth, 2000). Induction of the
neutrophil chemotaxin IL-8 is consistent with the ﬁnding of
neutrophil inﬁltration in the initial phase. The induction of monocyte
chemotaxins MIP-1α/β and MCP-1 is consistent with monocyte
inﬁltration that occurs later in the course of infection. Finally, the
robust expression of the lymphocyte chemotaxin IP-10 is likely
important in recruiting lymphocytes that are prominent in the airway
at latter stages of disease, and participate in the adaptive immune
response to inﬂuenza. It is important to recognize that strict
correlation of the autopsy ﬁndings with our present study is limited
by the fact that autopsy studies represent ﬁndings of the terminal
stages of inﬂuenza infection, while this current study examines virus-
host interactions throughout the course of the illness.
The elucidation of intracellular signaling pathways that are
activated by inﬂuenza A virus infection is important for the
understanding of both viral replication strategies and host defense
mechanisms. Here, we show that productive infection of lung slices
results in a moderate activation of all the subgroup of MAPK signaling
pathways, p38, ERK and JNK. Inhibition experiments showed that
individual pathways are important in induction of speciﬁc cytokines
and chemokines. However, as addition of all three inhibitors together
provided additional suppression of the cytokine and chemokine
responses, it is likely that multiple pathways play a role in cytokine
and chemokine induction by inﬂuenza virus. Our data extends studies
that show that p38 MAP kinase and JNK regulates RANTES production
by bronchial epithelial cells induced by inﬂuenza virus A. Also p38
MAP kinase has been identiﬁed as important for hyperinduction of
TNF-α expression in human macrophages due to the avian H5N1
inﬂuenza virus (Kujime et al., 2000; Lee et al., 2005). Ludwig et al.
have also demonstrated that inﬂuenza virus-induced activation of JNK
and AP-1 appears to be part of the innate antiviral response of the
MDCK and U937 cells (Ludwig et al., 2001). This is the ﬁrst report that
all the three MAPK signaling pathways are involved in cytokine
induction by inﬂuenza virus in cultured human lung tissue.
We chose to include an H3N2 inﬂuenza virus recently isolated
from the community in our study. The emergence of H3N2 inﬂuenza
virus strains as a major seasonal pathogen is a major public health
concern. This is because vaccination and antiviral therapy are the
mainstays of planning against yearly inﬂuenza outbreaks, and H3N2
vaccine production is problematic. Most human H3N2 inﬂuenza
viruses isolated after 1992 have lost the ability to agglutinate chickenred blood cells and only bind to human or guinea pig erythrocytes
(Gulati et al., 2005; Nobusawa et al., 2000). These viruses growwell in
MDCK cells, but they are difﬁcult to adapt to egg culture, which has
caused vaccine shortages. H3N2 viruses account for over 90% of the
strains that are adamantane resistant, which has created additional
public health issues (MMWR Journal Article, 2006). Understanding
the pathogenesis of H3N2 infection in order to develop novel
therapies is particularly important. Our use of both the H1N1 and
H3N2 strains will ensure that the results can be correlated with
responses studied using adapted strains in other models, and with the
responses that occur when the general public is exposed to non-
adapted inﬂuenza. In isolated human type II alveolar epithelial cells
(ATII), both H1N1 and H3N2 viruses induced release of pro-
inﬂammatory cytokines such as IL-6, IL-8, RANTES, MCP-1, and MIP-
1β. Although both viruses have similar ability to infect and replicate in
ATIIs, the wild-type strain PR8 is a stronger inducer of chemokines
and cytokines than A/Phil/82 (a H3N2 reassortant PR/8 virus, Wang
et al., 2009). Furthermore, since the ferret is considered the most
reproducible model similar to human in terms of pathological changes
and cytokine responses to inﬂuenza (Smith and Sweet, 1988), analysis
of the local ferret immune response to human inﬂuenza isolates of the
H1N1 and H3N2 subtypes showed that cytokine responses are
subtype-independent (Svitek et al., 2008). In A549 cells (a human
type II alveolar epithelial adenocarcinoma cell line), inﬂuenza A
H1N1-induced cytokinemRNA expressionwas detectable at 24 h after
infection, while H3N2 infection-induced mRNA expression after 12
h of infection. Although inﬂuenza A H1N1 virus induced somewhat
lower chemokine mRNA expression compared to H3N2 or inﬂuenza B
viruses, the chemokine protein induction was nearly equal for all the
inﬂuenza viruses tested (Veckman et al., 2006). In this study, despite
the large difference in these strains in terms of growth in egg culture
systems and adamantane resistance, we found that there were only
subtle differences in terms of the innate immune cytokine response to
H1N1 and H3N2 in human lung.
One research group studied the induction of the MAPK signal
cascade by two seasonal human inﬂuenza A viruses, A/HK/218449/
06 (H3N2) and A/HK/218847/06 (H1N1). Infection with H3N2 virus
resulted in substantially increased activation of ERK signaling
compared to that caused by H1N1 (Marjuki et al., 2007). Our data
agree with earlier results in primary macrophages that only modest
ERK and p38 signaling was induced during H1N1 infection (Lee et al.,
2005). Furthermore, modest JNK activation was also observed in our
model by H1N1.
Taken together, our results indicate that the human lung responds
to infection by the inﬂuenza virus by producing a robust cytokine and
chemokine response which recruits neutrophils, monocytes and
lymphocytes to participate in the innate immune response. We also
demonstrate that the production of the pro-inﬂammatory cytokines
and chemokines are causally related to the activation of the signaling
pathways ERK, JNK, and p38. This is the ﬁrst description of the initial
human lung innate immune response to inﬂuenza virus in a human
organ culture model.
Materials and methods
Preparation of inﬂuenza virus stock
The viruses used in this study include A/Oklahoma/309/06, a
Wisconsin/05 like H3N2 isolate, and A/PR/34, H1N1 virus. A/
Oklahoma/309/06 was isolated in the University of Oklahoma Health
Sciences Center clinical microbiology laboratory in 2006. The viruses
have been passaged in Madin–Darby canine kidney (MDCK) cells.
MDCK cells were cultured in supplemented Dulbecco's modiﬁed
Eagle's medium (DMEM). Viruses were grown in MDCK cells in
DMEM/F12 with ITS+ (BD Biosciences, Franklin Lakes, NJ) and
trypsin (Liu and Air, 1993), harvested at 72 h postinfection and titered
186 W. Wu et al. / Virology 396 (2010) 178–188by plaque assay in MDCK cells. There was no detectable endotoxin in
the ﬁnal viral preparations used in the experiments as determined by
limulus amebocyte lysate assay (Cambrex, Walkersville, MD). The
lower limit of detection of this assay is 0.1 EU/ml or approximately
20 pg/ml LPS.
Lung explant culture
Human lung tissue was obtained from patients undergoing lung
resection for cancer in accordance with protocols approved by the
Institutional Review Boards of the University of Oklahoma, Veterans
Administration Hospital, Baptist-Integris Hospital, St. Anthony's
Hospital, and Mercy Health Center, all of Oklahoma City, OK. Only
tissue that did not contain tumor was used for experiments. For
experiments onMAPK inhibition, lung tissue fromNDRI was also used
for comparison with tissue from surgeries. The tumor free lung tissue
was transported on ice in sterile Phosphate buffered saline (PBS)
containing 200 μg gentamicin/ml, 100 U penicillin/ml, 100 μg
streptomycin/ml, and 2.5 μg amphotericin B/ml (PBS+antibiotics)
and processed immediately. The subsegmental bronchi of lung tissue
with intact outer pleura were isolated and cannulated with a ﬂexible
Teﬂon catheter, and the lung segments were gently inﬂatedwith 37 °C
lung slice medium (LSM) containing 1.5% low-melting–low-gelling
agarose (BioWhittaker, Rockland, ME). LSM consisted of minimal
essential medium (Sigma Chemical Co., St. Louis, MO) supplemented
with 1.0 μg of bovine insulin/ml, 0.1 μg of hydrocortisone/ml, 0.1 μg of
retinyl acetate/ml, 200 μg of gentamicin/ml, 100 U of penicillin/ml,
100 μg of streptomycin/ml, and 1.25 μg of amphotericin B/ml. After
the agarose inﬂated lung was solidiﬁed, 1 cm diameter tissue cores of
non-emphysematous tissue were prepared and sliced into 500 μm
thick sections using a Krumdieck Tissue Slicer (Alabama Research and
Development, Munford, AL). During slicing, the cores were sub-
merged in chilled PBS + antibiotics. Each slice was placed in 0.5 ml of
LSM in a single well of a 24-well plate, then placed in a humidiﬁed
incubator at 37 °C in 5% CO2. The LSMwas replaced prior to subjecting
the slices to the experimental treatments.
Infection of human lung slices with inﬂuenza virus
After overnight incubation of the lung slices, the culture medium
was replaced with fresh LSM. For each data point, three lung slices
were each exposed to 6×106 PFU/ml of inﬂuenza virus PR8 and OK/
06, and allowed to incubate at 37 °C, 5% CO2 for the indicated periods.
Virus diluent was used as a negative control, and PMA (100 ng/ml)
was used as a positive control. Following stimulation for various
times, media supernatants were harvested and stored at−20 °C prior
to ELISA.
OK/06 H3N2 virus was reacted with Cy3 dye in 0.1 M sodium
carbonate buffer (pH 9.3) for 30 min at room temperature with
occasional mixing according to the manufacturer's protocol for
labeling proteins. The labeled virus was then dialyzed in PBS
containing 0.6 mM CaCl2 and 0.5 mM MgCl2 (CaMg-PBS ) for 72 h
with three buffer changes to remove unlabeled dye. The tissue slices
exposed to virus-free diluent were used as a negative control for
inﬂuenza virus detection.
RNA preparation and RNase protection assay (RPA)
Lung slices were harvested by homogenization in TRIzol Reagent
(Invitrogen, Carlsbad, CA), and the total RNAwas isolated according to
themanufacturer's protocol using glycogen (20mg/ml) as the carrier.
Triplicate slices yielded 8–10 μg total RNA, 6 μg of which were used for
a single RPA reaction.
Relative gene expression was determined with the RiboQuant
Multi-Probe RNase Protection Assay system (BD Biosciences). A
custom cytokine set was used containing probes for TNF-α, IL 12/p35, IP-10, IFN-γ, MIP-1α, MCP-1, IL-8 and IL-6. The template set
contained probes for ribosomal protein (L32) and GAPDH to use for
normalization of RNA loading. Labeled riboprobe was made with the
In vitro Transcription Kit (BD Biosciences) and (α-32P) UTP. The RPA
Kit (BD Biosciences) was used for hybridization of the probe with the
target RNA in the samples, and for digestion of unpaired transcripts.
Additional controls included a sample containing yeast total RNA, a
sample with the custom template control RNA, and one with
unprotected probe. The resulting mRNA duplexes were separated on
a standard 50 cm long, 0.4 mm thick polyacrylamide gel. The gel was
dried and imaged using a phosphorimager (Molecular Dynamics,
Sunnyvale, CA). The image was analyzed with ImageQuant 5.0
software (Molecular Dynamics) using the volume quantitation
method with histogram peak background subtraction. The identity
of each protected band in a sample lane was determined from the
position of the bands in the unprotected probe lane. Fold increase for
each RNA species over control samples prepared at the same time
points was determined after correction for loading using the L32 and
GAPDH standards.
Signal pathway inhibition and cytokine and chemokine protein
determination by ELISA
After overnight incubation of the lung slices, the culture medium
was replaced with fresh LSM. Lung slices were exposed to 6×106
PFU/ml of inﬂuenza virus PR8 and OK/06 in triplicate wells of a 24-
well plate and allowed to incubate at 37 °C for 24 h. Virus diluent was
used as a negative control, and PMA (100 ng/ml) was used as a
positive control.
To determine the effect of inhibition of the ERK, p38, and JNK
signaling pathways on cytokine induction, the speciﬁc inhibitors
U0126, SB203580 and SP600125 (Calbiochem, San Diego, CA) were
used, respectively. Lung slices were pre-incubated with 0.5 μM of
SB203580, 0.5 μM of SP600125 and 50 μM of U0126 for 4 h at 37 °C.
These optimized doses were determined using dose range experi-
ments in lung slices stimulated with PMA/LPS. The medium was
replaced with LSM, and the lung slices were exposed to 6×106 PFU/
ml of inﬂuenza virus PR8 and OK/06 for 20 h at 37 °C. The ﬁnal
concentration of the inhibitors was maintained throughout the
experiment. PMA (100 ng/ml) was used as a positive control, and
mock-infected slices were exposed to the same concentration of the
inhibitor solvent, dimethyl sulfoxide (DMSO), as present when all
three inhibitors were used. After incubation, the supernatants were
collected, centrifuged at 10,000×g for 2 min, transferred to a new
tube and stored at −20 °C.
Cytokine ELISA's were performed using anti-cytokine monoclonal
primary antibodies and biotinylated anti-cytokine polyclonal second-
ary antibodies (R&D Systems, Minneapolis, MN). As the MIP-1α
monoclonal antibody crossreacts with MIP-1β, the results were
expressed as MIP-1α/β levels. Plates were developed using the TMB
reagent (BD Biosciences).
Signaling pathway kinase assay
Human lung slices were maintained overnight at 37 °C, 5% CO2 in
0.5 ml LSM and the mediumwas replaced prior to stimulation. Four to
eight slices per condition were used for MAPK family assays. Slices
were stimulated with either 6×106 PFU/ml of inﬂuenza virus or PMA.
Mock-infected, negative control slices were exposed to an equivalent
volume of virus-free diluent. After incubation at 37 °C, 5% CO2 for the
indicated times, the slices were harvested and homogenized in 100 μl
cold RIPA lysis buffer. Clariﬁed lung slice homogenates containing 20–
30 μg protein were heat denatured in SDS–PAGE sample buffer. The
samples were separated on a 10% SDS–PAGE gel and then electropho-
retically transferred to polyvinylidene ﬂuoride (PVDF)membranes. To
detect activated, phosphorylated ERK, p38 or SAPK/JNK, the
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buffered saline (TBS) and then immunoblotted with speciﬁc afﬁnity-
puriﬁed, rabbit polyclonal antibodies (Cell Signaling Technology,
Beverly, MA). Identically prepared membranes were probed with
either rabbit polyclonal anti-ERK, anti-p38 or anti-SAPK/JNK anti-
bodies that recognized both phosphorylated and non-phosphorylated
forms of the signaling proteins (Cell Signaling Technology). The
membranes were developed with horseradish peroxidase-conjugated
goat anti-rabbit IgG (Cell Signaling Technology) and chemilumines-
cent reagents (Pierce Biotechnology, Rockford, IL). The developed
membranes were exposed to X-ray ﬁlm, and digital scans of the ﬁlm
were quantiﬁed using ImageQuant software (BD/MolecularDynamics,
Bedford, MA).
Cytokine immunohistochemistry on lung tissue explants
To examine which cell types in the lung tissue produced IP-10 and
MIP-1α after inﬂuenza infection, lung slices were exposed to 6×106
PFU/ml of inﬂuenza virus or virus diluent in fresh LSM and incubated
at 37 °C for 24 h. Brefeldin A (L C Laboratories, Wofford, MA) was
added at a concentration of 5 μg/ml to block protein export in order
to enhance cytokine detection. Following the incubation, the lung
slices were ﬁxed with 4% paraformaldehyde in PBS at room
temperature for 30 min and were then imbedded in parafﬁn.
Sections (3–5 μm) were mounted on glass slides and immunoprobed
overnight at 4 °C with a goat anti-human polyclonal antibody for IP-
10 (R&D Systems) or MIP-1α (Abcam, Cambridge, MA), a polyclonal
rabbit anti-NP serum (Zhang and Air, 1994) and an anti-CD 68
monoclonal antibody (Dakocytomation, Carpinteria, CA). After
washing, the sections were probed with a donkey anti-goat
secondary antibody conjugated to Alexa Fluor 350, a donkey anti-
rabbit secondary antibody conjugated to Alexa Fluor 546 and a
donkey anti-mouse secondary antibody conjugated to Alexa Fluor
647, and the cell nuclei were stained with SYTOX green (all from
Molecular Probes). Transmitted light and ﬂuorescent microscopy
images were obtained using a Leica SP2 MP Confocal microscope.
Statistical analysis
Where applicable, the data have been expressed as the means±
standard error of the mean (SEM). Statistical signiﬁcance was
determined by one-way ANOVA with Student-Newman-Keuls post
hoc correction for multiple comparisons. Signiﬁcance was considered
as Pb0.05.
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